GB201317889D0 - Product and use - Google Patents

Product and use

Info

Publication number
GB201317889D0
GB201317889D0 GBGB1317889.2A GB201317889A GB201317889D0 GB 201317889 D0 GB201317889 D0 GB 201317889D0 GB 201317889 A GB201317889 A GB 201317889A GB 201317889 D0 GB201317889 D0 GB 201317889D0
Authority
GB
United Kingdom
Prior art keywords
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1317889.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reneuron Ltd
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Priority to GBGB1317889.2A priority Critical patent/GB201317889D0/en
Publication of GB201317889D0 publication Critical patent/GB201317889D0/en
Priority to PCT/GB2014/053045 priority patent/WO2015052527A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB1317889.2A 2013-10-09 2013-10-09 Product and use Ceased GB201317889D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1317889.2A GB201317889D0 (en) 2013-10-09 2013-10-09 Product and use
PCT/GB2014/053045 WO2015052527A1 (en) 2013-10-09 2014-10-09 Microparticles, mirna and wound therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1317889.2A GB201317889D0 (en) 2013-10-09 2013-10-09 Product and use

Publications (1)

Publication Number Publication Date
GB201317889D0 true GB201317889D0 (en) 2013-11-20

Family

ID=49630448

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1317889.2A Ceased GB201317889D0 (en) 2013-10-09 2013-10-09 Product and use

Country Status (2)

Country Link
GB (1) GB201317889D0 (en)
WO (1) WO2015052527A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US10961531B2 (en) 2013-06-05 2021-03-30 Agex Therapeutics, Inc. Compositions and methods for induced tissue regeneration in mammalian species
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
WO2015095794A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
CN104894062A (en) * 2015-05-19 2015-09-09 暨南大学 Stem cell exosome patch and preparation method and application thereof
US10695293B2 (en) 2016-03-22 2020-06-30 Capricor, Inc. Method of preventing or treating radiation-induced dermatitis with extracellular vesicles
WO2017190000A1 (en) * 2016-04-29 2017-11-02 Advanced ReGen Medical Technologies, LLC Microrna compositions and methods of making and using same
KR101860266B1 (en) * 2016-07-01 2018-05-24 사회복지법인 삼성생명공익재단 Compositions for Treating Skin Wound Comprising Exosome Derived from Stem Cell Treated with Thrombin
JP6629770B2 (en) * 2017-01-19 2020-01-15 シスメックス株式会社 Method for assessing cell differentiation status
EP3604502A4 (en) * 2017-03-31 2021-01-06 Tokyo Metropolitan Institute of Medical Science Stable production and use of highly virulent enterovirus 71
KR101939368B1 (en) * 2017-06-13 2019-01-16 광주과학기술원 Diagnostic biomarker for alzheimer's disease and use thereof
CN111093681A (en) * 2017-07-16 2020-05-01 雷蒙特亚特特拉维夫大学有限公司 Human oral mucosal stem cell secretory proteome
WO2019103300A1 (en) * 2017-11-27 2019-05-31 (주)프로스테믹스 Mirna-containing composition for treating wounds and improving skin
US10717981B2 (en) 2018-01-18 2020-07-21 Advanced ReGen Medical Technologies, LLC Therapeutic compositions and methods of making and using the same
WO2019152522A1 (en) * 2018-01-30 2019-08-08 Histogen, Inc. Extracellular vesicles derived from cells cultured under hypoxic conditions and uses thereof
CN108373996A (en) * 2018-03-29 2018-08-07 王丽丽 A kind of preparation and application of the fat stem cell excretion body in face rejuvenation
WO2019246019A1 (en) * 2018-06-18 2019-12-26 Rush University Medical Center Use of apoptotic compensatory proliferation signaling vesicles in tissue repair and wound healing
US20210228643A1 (en) 2018-07-26 2021-07-29 Uniwersytet Jagiellonski N vivo delivery system of the genome dna modifying enzymes and the use thereof
CN110812525A (en) * 2019-12-27 2020-02-21 张伟 Aseptic collagen liquid of adipose-derived stem cell exosome and preparation method of application
CN113018501A (en) * 2020-12-15 2021-06-25 张平 Endothelial progenitor cell exosome medical dressing, preparation method and application thereof
CN112316114B (en) * 2021-01-04 2021-04-27 中科天诚(深圳)集团有限公司 Application of exosome in improving mesenchymal stem cell tissue repair function
CN113181421B (en) * 2021-05-12 2022-11-15 广州贝奥吉因生物科技股份有限公司 Hydrogel wound dressing with antibacterial and immunoregulation functions and preparation method thereof
CN113230406A (en) * 2021-05-20 2021-08-10 中南大学湘雅二医院 Application of miR-4769-3p inhibitor
CN114042163B (en) * 2021-12-28 2022-11-18 上海市皮肤病医院 Application of ALDH3A1/IL-17 shaft in preparation of drug for treating intractable ulcer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6468794B1 (en) 1999-02-12 2002-10-22 Stemcells, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
EP1261357B1 (en) 2000-02-11 2010-07-14 The Schepens Eye Research Institute, Inc. Isolation and transplantation of retinal stem cells
ES2557772T3 (en) 2004-06-09 2016-01-28 The University Court Of The University Of Edinburgh Neural stem cells
DE602005002430T2 (en) 2004-09-30 2008-06-19 Reneuron Ltd., Guildford cell line
HUE026536T2 (en) 2008-02-22 2016-06-28 Agency For Science Tech And Res (A Star) Mesenchymal stem cell particles
WO2011062244A1 (en) * 2009-11-18 2011-05-26 Kuroda Masahiko Carrier, method for producing same, and applications of same
WO2011088365A1 (en) 2010-01-14 2011-07-21 Organogenesis, Inc. Bioengineered tissue constructs and methods for producing and using thereof
GB201011589D0 (en) 2010-07-09 2010-08-25 Reneuron Ltd Therapeutic cells
WO2012020308A2 (en) * 2010-08-13 2012-02-16 The University Court Of The University Of Glasgow Cellular and molecular therapies
EP2629782B1 (en) * 2010-10-18 2019-02-20 Agency For Science, Technology And Research Use of exosomes derived from mesenchymal stem cells to promote or enhance hair growth

Also Published As

Publication number Publication date
WO2015052527A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
GB201317889D0 (en) Product and use
HK1225715A1 (en) Aza-pyridone compounds and uses thereof
GB201317887D0 (en) Product
GB201305277D0 (en) Novel combination and use
EP2990497A4 (en) Low-oxygen-purified steel and low-oxygen-purified steel product
GB201323008D0 (en) Compounds and uses thereof
IL244214A0 (en) Thienopiperidine derivative and use thereof
IL240248A0 (en) Met-binding agents and uses thereof
GB201301639D0 (en) Product and process
GB201307233D0 (en) Compounds and uses thereof
GB201323132D0 (en) New products and processes
GB201307989D0 (en) Novel combinations and use
GB201320992D0 (en) Complex and uses thereof
EP2946016A4 (en) Adenoviruses and their use
GB201309180D0 (en) Compounds and Their Uses
GB201301571D0 (en) Product and use
IL240177A (en) Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
IL235379A (en) Magnesium-containing products and uses thereof
GB201314610D0 (en) Compounds and their uses
GB201311769D0 (en) Product
GB201306248D0 (en) Compounds and their uses
GB201305297D0 (en) Novel agents and uses thereof
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201307049D0 (en) Catalysts and use thereof
GB201309328D0 (en) Product and use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)